NORWOOD, Mass., June 22, 2017 /PRNewswire/ -- Entrinsic Health Solutions, Inc., an innovative health sciences company dedicated to the development and commercialization of amino acid-based medical foods to address critical digestive health, nutrition, and hydration-related health issues, today announced an abstract highlighting the promising results of a pragmatic study of enterade® in reducing cancer therapy-induced gastrointestinal toxicity and dehydration. The abstract has been accepted for a scientific poster presentation at the Multinational Association of Supportive Care in Cancer (MASCC) conference to be held from June 22-24, 2017, in Washington DC.
"This study indicates that our Amino Acid Coupled Transport (A2CT) technology reduces many of the symptoms that arise from cancer therapy-induced gastrointestinal toxicity and dehydration. As anticipated, the results support enterade® as a first-in-class remedy for those who are experiencing side effects from the treatment of cancer. Moving forward, we are confident that enterade® will be the solution to a problem that many patients, healthcare providers, caregivers, and loved ones have been endlessly trying to address," said Stephen J Gatto, Chairman & CEO of Entrinsic Health Solutions.
The MASCC poster presentation will take place on June 23rd from 5:30 -7:00 p.m. in the e-poster station 3 & 4 by Dr. Laura Luque.
This poster presentation will be available on June 25th in the News & Media section of the Entrinsic Health Solutions website at www.entrinsichealth.com.
enterade®, is a proprietary, glucose free, medical food/beverage that provides select amino acids and electrolytes (potassium and sodium) - the nutrients needed to rebuild and protect the GI tract and deliver total body hydration to address the side effects for patients undergoing treatment of cancer. For more information, please visit us at www.enterade.com and connect with the brand on Facebook, Instagram, and Twitter.
About Entrinsic Health Solutions
Entrinsic Health Solutions, Inc., is an innovative health sciences company dedicated to the development and commercialization of amino acid based medical foods to address critical digestive health, nutrition and hydration related health issues. The Company's proprietary Amino Acid Coupled Transport (A2CT) Technology platform leverages gold-standard science and game-changing amino acid technology to address critical digestive and hydration-related health issues. A2CT technology uses select amino acids to facilitate active transport of electrolytes throughout the body, which delivers rapid hydration, decreased gut permeability and improved nutrient absorption, supporting long-term digestive health. For more information, please visit us at www.entrinsichealth.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/entrinsic-health-solutions-announces-data-from-poster-presentation-at-mascc-annual-meeting-300477982.html
SOURCE Entrinsic Health Solutions, Inc.